| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |